Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as vinorelbine, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some
block the ability of tumor cells to grow and spread. Others find tumor cells and help kill
them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor
cells by blocking blood flow to the tumor. Giving vinorelbine together with bevacizumab may
kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving vinorelbine together with
bevacizumab works in treating older patients with stage III or stage IV non-small cell lung
cancer.